2012
DOI: 10.1016/j.athoracsur.2011.05.017
|View full text |Cite
|
Sign up to set email alerts
|

Improved Survival but Marginal Allograft Function in Patients Treated With Extracorporeal Membrane Oxygenation After Lung Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
66
2
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 113 publications
(70 citation statements)
references
References 11 publications
1
66
2
1
Order By: Relevance
“…Although previous studies have examined the association between pretransplant psychosocial factors and long‐term outcomes , few have attempted to account for post‐transplant medical factors that may affect this association . For example, longer LOS following transplantation is a well‐known predictor of future clinical events due to the impact of acute infections, primary graft dysfunction, and other perioperative complications .…”
Section: Discussionmentioning
confidence: 99%
“…Although previous studies have examined the association between pretransplant psychosocial factors and long‐term outcomes , few have attempted to account for post‐transplant medical factors that may affect this association . For example, longer LOS following transplantation is a well‐known predictor of future clinical events due to the impact of acute infections, primary graft dysfunction, and other perioperative complications .…”
Section: Discussionmentioning
confidence: 99%
“…(137) With improvement in ECMO technology, including high performance membranes and coated circuits, veno-venous (VV) ECMO has been increasingly used with similar post-transplant outcomes and survival as VA-ECMO. (131, 135) Several groups have evaluated the use of extracorporeal life support (ECLS) with VV, VA, and arterio-venous ECMO as a bridge to lung transplantation. Future research is needed to identify optimal candidates, standardize management strategies, and understand the impact of ECLS on PGD risk.…”
Section: Prevention and Treatmentmentioning
confidence: 99%
“…4 The recently published Duke University experience highlights that venovenous ECMO was the routine treatment for severe PGD, suggesting perhaps a lower threshold for ECMO initiation compared to previous studies. 25 Over a 9 year period of time, 28 of 498 (6.0%) patients required ECMO. Patients were weaned 96% of the time, and survival rates were better compared to previously published reports: 82%, 64%, and 49% at 30 day, 1 year and 5 years, respectively.…”
Section: Commentary: the Pulmonologist's Perspective (Dr Lee)mentioning
confidence: 99%
“…While encouraging, the authors did notice worse allograft function in ECMO survivors after 3 years. 25 …”
Section: Commentary: the Pulmonologist's Perspective (Dr Lee)mentioning
confidence: 99%
See 1 more Smart Citation